The discussion examined the growing threat of antimicrobial resistance in oncology settings, the role of medical nutrition in improving outcomes and quality of life, and persistent challenges to patient safety across treatment pathways.
Throughout, gaps were identified, best practices shared, and a momentum for more integrated and resilient cancer care systems in Europe was generated.
The event was co-chaired by:
Alessandro Laviano, Professor at Sapienza University of Rome and Director of the European Society for Clinical Nutrition and Metabolism (ESPEN) Lifelong Learning Educational Programme; and
Ivana Dragojević, President of the Association for Liver Diseases Hronos and Vice-President of the European Liver Patients' Association (ELPA).
The full recording of the roundtable discussion is now available here.
15:00 - 15:10 | Welcome and introductions
15:10 - 15:55 | Medical Nutrition
Co-chaired by Alessandro Laviano and Katrien Van Laere, Chief Medical & Scientific Officer at Danone.
This session brought attention to the burden and under-recognition of cancer-related malnutrition, the role of medical nutrition, and the existing gaps in EU policy regarding this issue.
Presenting speaker:
Panel respondents:
15:55 - 16:40 | Antimicrobial Resistance
Co-chaired by Alessandro Laviano and Najy Alsayed, Global Therapeutic Area Head for Infectious Diseases, Menarini.
The session examined the impact of antimicrobial resistance for cancer care in Europe, the health economic aspect to its incidence and control and the political opportunities for improved response.
Presenting speaker:
Panel respondents:
16:40 - 17:25 | Healthcare Acquired Infections
Co-chaired by Ivana Dragojević, Vice-President and Treasurer, European Liver Patients' Association (ELPA) and Jose Luis Gomez Ruiz, Vice President Europe of Becton, Dickinson and Company (BD).
The session considered some of the principal patient safety risks that can be present in oncology treatment with a special look at healthcare acquired infections. Practices to mitigate and prevent these risks from around the globe were considered and discussed.
Presenting speaker:
Panel respondents:
17:25 - 17:30 | Event conclusions